Niche Biopharmaceuticals biopharma company that offers anti-infective immunomodulatory therapeutics for antiviral treatment.
Niche Biopharmaceuticals has raised $200K in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Niche Biopharmaceuticals is headquartered in Shorewood, United States.
Niche Biopharmaceuticals biopharma company that offers anti-infective immunomodulatory therapeutics for antiviral treatment.
Niche Biopharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Niche Biopharmaceuticals — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/niche-biopharmaceuticals. Accessed October 4, 2026.
VCBacked. (2026). Niche Biopharmaceuticals — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/niche-biopharmaceuticals
{{cite web |title=Niche Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/niche-biopharmaceuticals |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated